enVVeno Medical (NVNO) Return on Equity (2018 - 2020)

Historic Return on Equity for enVVeno Medical (NVNO) over the last 3 years, with Q3 2020 value amounting to 1.73%.

  • enVVeno Medical's Return on Equity rose 1300.0% to 1.73% in Q3 2020 from the same period last year, while for Sep 2020 it was 1.73%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 5.07% for FY2019, which is N/A changed from last year.
  • According to the latest figures from Q3 2020, enVVeno Medical's Return on Equity is 1.73%, which was up 1300.0% from 12.49% recorded in Q1 2020.
  • enVVeno Medical's 5-year Return on Equity high stood at 1.73% for Q3 2020, and its period low was 12.49% during Q1 2020.
  • For the 3-year period, enVVeno Medical's Return on Equity averaged around 3.96%, with its median value being 2.82% (2018).
  • The largest annual percentage gain for enVVeno Medical's Return on Equity in the last 5 years was 1300bps (2020), contrasted with its biggest fall of -92400bps (2020).
  • enVVeno Medical's Return on Equity (Quarter) stood at 2.82% in 2018, then plummeted by -34bps to 3.77% in 2019, then skyrocketed by 54bps to 1.73% in 2020.
  • Its last three reported values are 1.73% in Q3 2020, 12.49% for Q1 2020, and 3.77% during Q4 2019.